Terns Pharmaceuticals, Inc. (DELISTED) (TERN:DL)
52.95
0.00 (0.00%)
USD |
NASDAQ |
May 14, 16:00
Terns Pharmaceuticals EPS Diluted (Quarterly) : -0.2395 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Merck & Co., Inc. | -1.715 |
| Corcept Therapeutics, Inc. | -0.2988 |
| Eli Lilly & Co. | 8.255 |
| Bristol Myers Squibb Co. | 1.308 |
| Nektar Therapeutics | -1.815 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -23.57M |
| Total Expenses (Quarterly) | 23.57M |
| Enterprise Value | 5.093B |
| Earnings Yield | -1.95% |
| Normalized Earnings Yield | -1.950 |